Kenvue is exploring the sale of some of its skin health and beauty brands, four people familiar with the matter said on ...

Shares of Kenvue led S&P 500 decliners Tuesday after the consumer health giant's chief executive indicated the firm faces ...

In appraisal of Kenvue’s visual identity, the logo for the independent new company is said to represent Johnson & Johnson’s timelessness, while “allowing space for its iconic brands to have ...

Dan Loeb's Third Point acquired an 8.9 million stake in Kenvue in Q1 2025, making it a top five holding. Kenvue updated its FY25 outlook to reflect higher tariff costs and currency impacts ...

Kenvue aims to maintain its momentum as a Fortune 500 company and play a pivotal role in the wellness industry. The Fortune 500, now in its 71st year, is an annual ranking by Fortune magazine of ...

Shares of Kenvue (NYSE:KVUE) are under pressure Tuesday and experiencing their worst day since splitting from Johnson & Johnson (JNJ) and going public in 2023 after CEO Thibaut Mongon warned of ...

Kenvue stock slides on seasonal demand concerns View all comments (0) 0 Latest comments Post Comment Guidelines Trade With A Regulated Broker Indices Commodities Bonds Stocks US 30 41,781.50-390.2 ...

Kenvue has a better P/E ratio of 42.38 than the aggregate P/E ratio of 36.56 of the Personal Products industry. Ideally, one might believe that Kenvue Inc. might perform better in the future than ...

SUMMIT, N.J., June 02, 2025--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced it has made the prestigious ...

Wide-moat Kenvue's shares declined roughly 6% after the firm hinted at persistent market challenges at an investor conference. Management pointed to two dynamics—inventory destocking and weak ...

Shares of Kenvue Inc. KVUE shed 1.59% to $23.55 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.56% to 5,888.55 and ...